An eye on a tumor-killing supplement
It often turns out that nutrients have multiple benefits -- helping you stay healthy in ways you might not imagine. Take the carotenoid called zeaxanthin that's related to vitamin A. This nutrient has long been used, along with another carotenoid called lutein, to help improve vision in folks dealing with age-related macular degeneration. And the organic pigment that acts as an antioxidant is found in good supply in dark green leafy vegetables, oranges, grapes, mango, tangerines and corn.
The Cleveland Clinic says zeaxanthin also helps prevent liver disease, fights atherosclerosis, and protects skin from damage by blue light. And now researchers from the University of Chicago Medical Center have found that it also strengthens the cancer-fighting activity of T-cells in your immune system and improves the benefits of immunotherapy in cancer treatment. In the lab, zeaxanthin specifically helped KO melanoma, multiple myeloma, and glioblastoma tumor cells. Wow!
I mention this because it makes sense to focus on anti-cancer nutritional options we know about and integrate them into your diet daily. After all, from 2010 through 2019, the incidence of 14 types of cancer, including breast and colorectal cancer, increased among people of all ages. And it's thought that the epidemic of obesity is a huge factor. So, if you're at high risk for cancer or have been diagnosed, ask your doctor about taking zeaxanthin supplements (they're very safe). And for the full range of nutritional warriors that can protect and restore your long-term health, check out my book, "What to Eat When."
Health pioneer Michael Roizen, M.D., is chief wellness officer emeritus at the Cleveland Clinic and author of four No. 1 New York Times bestsellers. Check out his latest, "The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow," and find out more at www.4YOUngevity.com. Email your health and wellness questions to Dr. Mike at questions@4YOUngevity.com.
(c)2023 Michael Roizen, M.D.
Distributed by King Features Syndicate, Inc.
(c) 2025 Michael Roizen, M.D. Distributed by King Features Syndicate, Inc.
Comments